SHEILA ARNAUD: Open Payments
NPI 1013183714 · PORT ARTHUR, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$400 in 15 payments from 11 companies in 2025. Trend: 2023 $750 · 2024 $209 · 2025 $400
Food & beverage: $400
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 1 | $80 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $67 |
| Novo Nordisk Inc | 2 | $48 |
| MILLICENT US INC | 2 | $45 |
| ABBVIE INC. | 1 | $26 |
| Lilly USA, LLC | 1 | $25 |
| Exeltis, USA Inc. | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Exact Sciences Corporation | 1 | $21 |
Products named: Korlym, UBRELVY, ZEPBOUND, SLYND, INTRAROSA, Lynkuet, CAPLYTA, FEMLYV.
Industry payments across TX — which companies pay providers there.
